Multiple-drug-resistant mutants were isolated from Pseudomonas aeruginosa PAO1 on agar plates containing ofloxacin and cefsulodin. These mutants were four to eight times more resistant to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol than the parent strain was. In contrast, these mutants showed no significant changes in their susceptibilities to all carbapenems except meropenem. In these mutants, the amounts of an outer membrane protein with an apparent molecular weight of 49,000 (designated OprM) were increased compared with the amount in PA01. Multiple-drug-resistant mutants of this type were also isolated from PAO1 on agar plates containing meropenem. Approximately 5% of clinical isolates showed cross-resistance to meropenem, cephems, and quinolones, concomitant with overproduction of OprM. Moreover, these two phenotypes, i.e., multiple-drug resistance and overproduction of OprM, were cotransferable by transduction. These data suggest that overproduction of OprM is associated with cross-resistance to meropenem, cephems, and quinolones in P. aeruginosa. The ofloxacin-cefsulodin-resistant mutant required higher concentrations of meropenem to induce 13-lactamase than PA01 did, indicating the possibility that this mutation involves decreased outer membrane permeability to meropenem.
Pseudomonas aeruginosa is a clinically important pathogen because of its natural resistance to many antimicrobial agents. Only a few antimicrobial agents, such as carbapenems and quinolones, have potent antibacterial activity against a broad spectrum of bacteria including P. aeruginosa. The main reason for this bacterial resistance is thought to be the organism's low outer membrane permeability to antimicrobial agents (1, 22) . In recent years, the number of P. aeruginosa clinical isolates that are resistant to some of 19, 21) . This is the reason that these strains do not show cross-resistance to other antimicrobial agents, including cephems and penicillins. However, we recently isolated meropenem-resistant P. aeruginosa strains from clinical sources, and these strains show cross-resistance to cephems, quinolones, and some other antibiotics but not to imipenem and panipenem.
In this article, we describe the association of this crossresistance with overproduction of an outer membrane pro- these antibiotics, especially to quinolones, has increased. Carbapenems, such as imipenem, panipenem, and meropenem, have potent antibacterial activities against P. aeruginosa. However, carbapenem-resistant P. aeruginosa strains have already been isolated clinically. Most of them lack the outer membrane protein D2 (2, 15, 20) , which forms a specific channel for basic amino acids and carbapenems ( Glaxo Japan, Tokyo, Japan; cefoperazone, Toyama Chemical Co., Tokyo, Japan; carbenicillin, Fujisawa Pharmaceutical Co., Osaka, Japan; ofloxacin, Daiichi Pharmaceutical Co., Tokyo, Japan; ciprofloxacin, Bayer Pharmaceutical Co., Osaka, Japan; tetracycline, Lederle Japan, Tokyo, Japan; chloramphenicol, Sankyo Co; Ltd.; and gentamicin and cephaloridine, Shionogi Pharmaceutical Co., Osaka, Japan.
Bacterial Assay of outer membrane proteins. Outer membrane proteins of P. aeruginosa grown in L broth were prepared and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (6) .
Assay of 13-lactamase. Cells were grown overnight in Mueller-Hinton broth and then diluted with a 20-fold volume of the same prewarmed medium and incubated for 2 h at 37°C with shaking. A 1/20th volume of meropenem solution was added, and the incubation was continued for 1 h at 37°C. Samples were withdrawn and mixed with an equal volume of ice-cold saline containing 800 ,ug of chloramphenicol per ml to inhibit protein synthesis. Cells were harvested by centrifugation at 7,000 x g for 10 min at 4°C, suspended in ice-cold 10 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (pH 7.5), and then broken with a sonicator (Branson Sonic Power Co., Danbury, Conn.) for 20 s. Unbroken cells were removed by centrifugation. The enzyme activity in the supernatant was assayed spectrophotometrically at 260 nm with 50 ,uM cephaloridine in 10 mM MOPS buffer (pH 7.5) as a substrate at 37°C.
Transduction. Transductions were performed as described by Haas and Holloway (8) .
RESULTS
Susceptibilities and outer membrane proteins of meropenem-resistant clinical isolates. The majority of P. aeruginosa clinical isolates showed higher susceptibilities to meropenem than to imipenem, as reported previously by Edwards et al. (4) . However, approximately 5% of them showed lower susceptibilities to meropenem than to imipenem. The susceptibilities of six P. aeruginosa clinical isolates that showed lower susceptibilities to meropenem than to imipenem are shown in Table 1 , along with minimal concentrations required to inhibit 50% of randomly selected clinical isolates. These strains also showed reduced susceptibilities to cephems (i.e., cefsulodin, ceftazidime, and cefoperazone), carbenicillin, quinolones (i.e., ofloxacin and ciprofloxacin), tetracycline, and chloramphenicol.
The amount of an outer membrane protein with an apparent molecular weight of 49,000 (designated OprM [outer membrane protein responsible for multiple-drug resistance]) was increased in each of the six P. aeruginosa strains (Fig.  1 , lanes 7 through 12) compared with the amounts in strains that showed higher susceptibilities to meropenem than to imipenem (Fig. 1, lanes 2 through 6 ). There were also some differences in the amounts of other proteins. The amounts of D2 protein tended to be decreased in the strains that showed lower susceptibilities to all carbapenems. However, the differences in the amount of OprM were the most remarkable.
Isolation of meropenem-resistant mutants from PAO1. To study the mechanism of resistance to meropenem in P. aeruginosa, we isolated meropenem-resistant mutants from P. aeruginosa PA01 on L-agar plates containing 3 ,ug of meropenem per ml. They were isolated at a frequency of 10-9 to 10-8. These mutants fell into two types according to their susceptibilities to meropenem and other antimicrobial agents. Table 2 with the exception of meropenem, as the weakly meropenem-resistant mutants. The highly meropenem-resistant mutants were fourfold less susceptible to meropenem than the weakly meropenem-resistant mutants. The highly meropenem-resistant mutants also had reduced susceptibilities to cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol. There were no significant changes in the susceptibilities of the highly meropenem-resistant mutants to gentamicin. Figure 2 shows outer membrane protein profiles of six meropenem-resistant mutants compared with that of their parent strain, PAQ1. None of the mutants produced D2 protein. The amounts of OprM were increased in the highly meropenem-resistant mutants, MR9, MR27, and MR36, compared with the amounts in PA01 and the weakly meropenem-resistant mutants, MR02, MR08, and MR39. The amounts of all othe'r proteins were comparable to those of PAO1.
Isolation of ofloxacin-cefsulodin-resistant mutants from PAO1. To study the mechanism of cross-resistance to meropenem, cephems, and quinolones in P. aeruginosa, we isolated ofloxacin-cefsulodin-resistant mutants from PA01 on L-agar plates that contained 1 ,g (each) of ofloxacin and cefsulodin per ml. The ofloxacin-cefsulodin-resistant mutants were obtained at a frequency of 10-8 to 10-7. The susceptibilities of tl*fee mutants, OCR1, OCR3, and OCR4, to antimicrobial agents are shown in Table 2 . The ofloxacincefsulodin-resistant mutants were four to eight times more resistant to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol than the parent strain was. In contrast, these mutants showed no significant changes in their susceptibilities to all the carbapenems except meropenem. There were no significant changes in the susceptibilities of these mutants to gentamicin. Figure 3 shows outer membrane protein profiles of eight ofloxacin-cefsulodin-resistant mutants together with those of PA01 and a highly meropenem-resistant mutant, MR27. The amounts of OprM were increased in all of the mutants compared with the amount in PAO1. There were no significant changes in the production of other proteins.
13-Lactamase inducibility of the ofloxacin-cefsulodin-resistant mutant. PAQ1 and its ofloxacin-cefsulodin-resistant mutant, OCR1, were tested for their 13-lactamase inducibility to check for the possibility of a change in the permeability of the mutant to meropenem. They were incubated with various concentrations.(0 012 to 3.13 p,g/ml) of meropenem for 1 h, and the induced 3-lactamase was quantified. There was a progressive induction of f-lactamase in both PAQ1 and OCR1 as the concentration of meropenem was increased (Fig. 4) penem, panipenem, and L-627 as PAO1 to induce the same levels of 3-lactamase (data not shown).
Transduction of multiple-drug resistance. Cell-free lysate of the generalized transducing phage F116L was prepared with OCR1 and used for transduction to a recipient, PA0969 (proC130). The transfer of amino acid prototrophy was used as the primary criterion of selection for transductants. Eighty-seven transductants were obtained on minimal medium containing glucose as the only carbon source. Twentyone (24%) of 87 transductants isolated grew on L-agar plates that contained 1 ,ug (each) of ofloxacin and cefsulodin per ml. Table 3 shows the susceptibilities of three representative transductants that were resistant to ofloxacin and cefsulodin. They show the same phenotype of resistance to the donor, OCR1. Figure 5 shows outer membrane protein profiles of nine representative transductants that showed multiple-drug resistance. Each of them produced a higher amount of OprM than the recipient strain, PA0969. (Fig. 1, 2 , and 5), it was independent of their susceptibilities to antibiotics. This protein was probably an esterase (14) , and it seemed not to be related to multiple-drug resistance.
Two types of quinolone resistance in P. aeruginosa are well known: (i) alterations in DNA gyrase (9, 10, 17, 18) and (ii) alterations in outer membrane permeability (3, 5, 9, 17, 18) . nalB mutants are known to show resistance to quinolones, ,B-lactams, tetracycline, and chloramphenicol which is due to decreased outer membrane permeability (5, 17) . nalB andproC are reported to be cotransducible at a frequency of 2.5% with phage G101 (17) . We showed that the mutation for multiple-drug resistance and proC in OCR1 were cotransducible at a frequency of 24% with phage F116L. These results strongly suggest that our isolated ofloxacin-cefsulodin-resistant mutants probably have mutations at the nalB locus.
Livermore and Yang (12) reported that carbenicillin-resistant mutants of P. aeruginosa had decreased susceptibilities to meropenem, cephems, penicillins, nalidixic acid, tetracycline, and chloramphenicol but not to imipenem. This phenotype of resistance is similar to that of our isolated mutants. However, those authors did not mention changes in the outer membrane protein profiles, except for a decreased expression of D2 protein. Multiple-drug-resistant mutants that show cross-resistance to quinolones and imipenem have also been reported (5, 16) . In these strains, resistance to imipenem seems to result from decreased production of D2 protein. These strains have an nfxC mutation, which is different from the nalB mutation (5) .
Decreases in susceptibility to meropenem, associated with overproduction of OprM in our PAO1 mutants, were seen in both D2-producing and D2-deficient strains, whereas the level of resistance to meropenem was higher in D2-deficient strains than in D2-producing strains. This indicates that permeation through the D2 channel is not responsible for the mechanism(s) of the resistance associated with overproduction of OprM.
Komatsu et al. (11) reported that introduction of the romA4 gene of Enterobacter cloacae into Escherichia coli resulted in resistance to ampicillin, cephems, quinolones, tetracyclines, and chloramphenicol, with the concomitant appearance of a new outer membrane protein. Nicas and Hancock (13) also reported that overexpression of outer membrane protein Hi in P. aeruginosa resulted in decreased susceptibilities to gentamicin, polymyxin B, and EDTA. They hy-pothesized that Hi protein replaces divalent cations at negatively charged sites on lipopolysaccharides and blocks penetration of these antibiotics. The function of OprM in P. aeruginosa is unclear. It is, however, possible that overproduced OprM interacts with either lipopolysaccharides or phospholipids and thus alters outer membrane permeability to meropenem, cephems, carbenicillin, quinolones, tetracycline, and chloramphenicol through an unknown penetration pathway(s).
Our data suggest that overproduction of OprM, with an associated lack of D2 protein, leads to higher resistance to meropenem in P. aeruginosa. Meropenem may select this type of multiple-drug-resistant strains.
